Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Stage II Gastric Cancer”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT02611024
What this trial is testing

Pharmacokinetic Study of Lurbinectedin in Combination With Irinotecan in Patients With Selected Solid Tumors

Who this might be right for
Advanced Solid TumorsGlioblastomaSoft Tissue Sarcoma (Excluding GIST)+9 more
PharmaMar 316
Testing effectiveness (Phase 2)UnknownNCT01803503
What this trial is testing

Docetaxel With or Without Low-dose, Short Course Sunitinib in Refractory Solid Tumors

Who this might be right for
Solid TumorsBreast CancerNon-small Cell Lung Cancer+2 more
National University Hospital, Singapore 80
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06374888
What this trial is testing

Nilatinib Maleate Tablets Combined With Capecitabine in the Treatment of HER2-positive Advanced Esophageal/Esophagogastric Junction/Gastric Adenocarcinoma With Brain Metastases

Who this might be right for
Her2-positive Advanced Esophageal/Esophagogastric Junction/Gastric Adenocarcinoma With Brain Metastasis
Convalife (Shanghai) Co., Ltd. 28
Testing effectiveness (Phase 2)Study completedNCT00011960
What this trial is testing

Chemotherapy and Radiation Therapy With or Without Fluorouracil in Treating Patients With Cancer of the Stomach Who Have Undergone Surgery

Who this might be right for
Esophageal CancerGastric Cancer
Radiation Therapy Oncology Group
Testing effectiveness (Phase 2)UnknownNCT00384878
What this trial is testing

Study of Cetuximab Plus P-HDFL for the First-Line Treatment of Advanced Gastric Cancer

Who this might be right for
Stomach Neoplasms
Far Eastern Memorial Hospital 35
Testing effectiveness (Phase 2)Looking for participantsNCT05934331
What this trial is testing

A LM-302 Combination With Other Anti-Tumor Therapies Phase ll Study

Who this might be right for
Malignant Neoplasms of Digestive Organs
LaNova Medicines Zhejiang Co., Ltd. 276
Testing effectiveness (Phase 2)Ended earlyNCT01365130
What this trial is testing

Chemotherapy for Patients With Gastroesophageal Cancers Who Have Progressed After One Prior Chemo Regimen

Who this might be right for
EsophagealGastrooesophageal CancerGastric Cancer
howard safran 15
Testing effectiveness (Phase 2)Study completedNCT04065139
What this trial is testing

Pressurized Intraperitoneal Aerosol Chemotherapy (PIPAC) in Gastric Carcinomatosis. Phase II Randomized Study

Who this might be right for
Gastric AdenocarcinomaCancer MetastaticChemotherapy Effect
Assistance Publique - Hôpitaux de Paris 66
Testing effectiveness (Phase 2)Ended earlyNCT02485834
What this trial is testing

FDG-PET Directed Treatment in Improving Response in Patients With Locally Advanced Stomach or Gastroesophageal Junction Cancer

Who this might be right for
Adenocarcinoma of the Gastroesophageal JunctionGastric AdenocarcinomaGastric Cancer
Alliance for Clinical Trials in Oncology 5
Testing effectiveness (Phase 2)Temporarily pausedNCT00568529
What this trial is testing

Combination of Capecitabine and Oxaliplatin in Patients With Relapsed or Refractory Gastric Cancer

Who this might be right for
Gastric Cancer
Fudan University 30
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06551896
What this trial is testing

Pemigatinib and Immune Checkpoint Inhibitor Treated FGFR1/2/3 Alteration Advanced Solid Tumor

Who this might be right for
Urothelial CarcinomaBreast NeoplasmsLung Cancer+3 more
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University 30
Testing effectiveness (Phase 2)Looking for participantsNCT06157996
What this trial is testing

Lenvatinib Plus Tislelizumab and CapeOX as First-Line Treatment for Advanced GC/GEJC With Positive PD-L1 and Low TMEscore

Who this might be right for
Gastric Cancer
Nanfang Hospital, Southern Medical University 92
Testing effectiveness (Phase 2)Study completedNCT02725424
What this trial is testing

Optimizing the Strategy for Preoperative Chemotherapy in Locally Advanced Gastric/Gastroesophageal Cancer

Who this might be right for
Gastric Cancer
Chinese Academy of Medical Sciences 180
Testing effectiveness (Phase 2)Study completedNCT01941316
What this trial is testing

Study of Carfilzomib With Irinotecan in Irinotecan-Sensitive Malignancies and Small Cell Lung Cancer Patients

Who this might be right for
Small Cell Lung CarcinomaNon Small Cell Lung CarcinomaIrinotecan Sensitive Cancers
Cancer Research and Biostatistics Clinical Trials Consortium 78
Testing effectiveness (Phase 2)Looking for participantsNCT07289997
What this trial is testing

Iparomlimab and Tuvonralimab Combined With Apatinib and Irinotecan Hydrochloride for the Treatment of Advanced Alpha-fetoprotein-producing Gastric Cancer (AFPGC)

Who this might be right for
AFP Gastric or Gastroesophageal Junction AdenocarcinomaPD-1/CTLA-4AFPGC+1 more
Hebei Medical University Fourth Hospital 39
Testing effectiveness (Phase 2)Ended earlyNCT00354224
What this trial is testing

Capecitabine and Oxaliplatin in Treating Patients With Locally Advanced, Unresectable, or Metastatic Stomach Cancer

Who this might be right for
Gastric Cancer
Medical University of South Carolina 10
Testing effectiveness (Phase 2)Study completedNCT03755440
What this trial is testing

PD-1 Antibody in EBV Positive Metastatic Gastric Cancer Patients.

Who this might be right for
Gastric Cancer Stage IVEBV
Sun Yat-sen University 6
Early research (Phase 1)Study completedNCT03434262
What this trial is testing

SJDAWN: St. Jude Children's Research Hospital Phase 1 Study Evaluating Molecularly-Driven Doublet Therapies for Children and Young Adults With Recurrent Brain Tumors

Who this might be right for
Anaplastic AstrocytomaAnaplastic EpendymomaAnaplastic Ganglioglioma+53 more
St. Jude Children's Research Hospital 68
Testing effectiveness (Phase 2)WithdrawnNCT04180761
What this trial is testing

Hyperthermic Intraperitoneal Chemoperfusion (HIPEC) in Gastric Cancer

Who this might be right for
Gastric Neoplasms
University Hospital Tuebingen
Testing effectiveness (Phase 2)Ended earlyNCT00335959
What this trial is testing

S0425 Oxaliplatin, Capecitabine, and RT in Treating Patients W/Stomach Cancer That Can Be Removed By Surgery

Who this might be right for
Gastric Cancer
SWOG Cancer Research Network 7
Next Page